Improve walking with red light
- Trial ID
- NCT06916260
- Official Title
- Light Therapy Intervention in Individuals With Parkinson's Disease
- Goal
- Improve walking with red light
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Delaware
- Study Type
- INTERVENTIONAL
- Enrollment
- 20 participants
- Conditions
- Parkinson Disease
- Interventions
- Red Light (PDT), Placebo
Plain-Language Summary
The goal is to see whether repeated red light therapy can improve motor symptoms, walking endurance, and related problems in people with Parkinson's by helping brain and muscle cells work better. The approach uses low-level red light phototherapy versus a placebo light, aiming to boost mitochondrial energy production and reduce inflammation so nerve cells function more effectively, and it would be used alongside, not instead of, levodopa if helpful. They are enrolling people aged 50 to 80 with a Parkinson's diagnosis who can walk unassisted for 2 minutes and who can briefly stop PD meds for testing, and they exclude folks with DBS, photosensitivity, recent head or neck injuries, other neurological conditions, cancer history, or certain psychiatric disorders.
Locations
- University of Delaware STAR Tower, Newark, Delaware, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Red Light (PDT). The goal is to see whether repeated red light therapy can improve motor symptoms, walking endurance, and related problems in people with Parkinson's by helping brain and muscle cells work better. The approach uses low-level red light phototherapy versus a placebo light, aiming to boost mitochondrial energy production and reduce inflammation so nerve cells function more effectively, and it would be used alongside, not instead of, levodopa if helpful. They are enrolling people aged 50 to 80 with a Parkinson's diagnosis who can walk unassisted for 2 minutes and who can briefly stop PD meds for testing, and they exclude folks with DBS, photosensitivity, recent head or neck injuries, other neurological conditions, cancer history, or certain psychiatric disorders.
- Who can participate?
- Participants must be between 50 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 10 months.